Mark Baxter

21PUBLICATIONS
68CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersMolecular targetsEpidemiological modellingAboriginal and Torres Strait Islander engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 15, 2026
Quality of Outcome Reporting for Older Subgroups in FDA Registration Gastroesophageal Cancer Trials (2010-2024): A Systematic Review.

|Jan 12, 2026
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United Kingdom.

Joseph Salf, Aimee Cunningham, Dinakshi Shah

|Jul 04, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.

Lindsay C Spender, Dale M Watt, Mark A Baxter

|Jul 02, 2025
KERMIT: Performance indicators in electronic patient reported outcome measures: a modified Delphi.

Nathaniel Luke Hatton, Mark Baxter, Sally Lewis

|Feb 26, 2025
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)-A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial.

Yuewei Tao, Chim C Lang, Russell D Petty

|Jan 31, 2025
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study.

Mark A Baxter, Michael Rowe, Kieran Zucker

Pageof 4

Frequent Collaborators

4 joint publications

Russell D Petty

3 joint publications

Michael Rowe

3 joint publications

Peter S Hall

2 joint publications

Cong Zhou